ONWDB logo

Onward Medical BATS-CHIXE:ONWDB Stock Report

Last Price

€6.12

Market Cap

€163.8m

7D

0%

1Y

n/a

Updated

12 May, 2024

Data

Company Financials +

Onward Medical N.V.

BATS-CHIXE:ONWDB Stock Report

Market Cap: €163.8m

ONWDB Stock Overview

A medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. More details

ONWDB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Onward Medical N.V. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Onward Medical
Historical stock prices
Current Share Price€6.12
52 Week High€6.12
52 Week Low€6.12
Beta0.79
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-36.25%

Recent News & Updates

Recent updates

Shareholder Returns

ONWDBGB Medical EquipmentGB Market
7D0%5.4%3.2%
1Yn/a-6.0%10.9%

Return vs Industry: Insufficient data to determine how ONWDB performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how ONWDB performed against the UK Market.

Price Volatility

Is ONWDB's price volatile compared to industry and market?
ONWDB volatility
ONWDB Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.3%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.6%

Stable Share Price: ONWDB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ONWDB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
201496Dave Marverwww.onwd.com

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.

Onward Medical N.V. Fundamentals Summary

How do Onward Medical's earnings and revenue compare to its market cap?
ONWDB fundamental statistics
Market cap€163.79m
Earnings (TTM)-€36.20m
Revenue (TTM)€500.00k

327.6x

P/S Ratio

-4.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ONWDB income statement (TTM)
Revenue€500.00k
Cost of Revenue€3.00m
Gross Profit-€2.50m
Other Expenses€33.70m
Earnings-€36.20m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.05
Gross Margin-500.00%
Net Profit Margin-7,240.00%
Debt/Equity Ratio46.3%

How did ONWDB perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/12 02:22
End of Day Share Price 2024/02/13 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Onward Medical N.V. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dylan van HaaftenBryan Garnier & Co
Maria Vara FernándezBryan Garnier & Co
David SeynnaeveDegroof Petercam